CompletedNot Applicable

Use of Amphetamine-type Stimulants & Its Relationship With HIV Incidence and Antiretroviral Adherence Among MSM and TG

Thailand510 participantsStarted 2016-11-15

Plain-language summary

There are two stages in the study. In Stage 1, 2000 Thai MSM, MSW and TGW/TGSW will be screened at the Thai Red Cross Anonymous Clinic (TRCAC) or Besides walk-in clients of TRCAC, potential participants could be referred to TRCAC by Rainbow Sky Association of Thailand (RSAT), Service Workers In Group (SWING) Foundation and Sisters Foundation. Each participant will complete a short standardized questionnaire on risk behavior, including use of amphetamine-type stimulants (ATS) and other drugs. HIV testing will be done following usual HIV testing and counseling (HTC) guidelines. Stage 1 will collect data on ATS use in the community. The results from stage 1 will also be used to stratify participants for inclusion in stage 2 of the study. Participants from the screening will be invited to participate in stage 2 of the study, which is the longitudinal cohort study. Recruitment will be stratified by HIV status and ATS use as listed in to ensure an adequate number of ATS users for data analysis. Participants in stage 2 will follow-up every 6 months for 18 months.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Stage 1 Inclusion Criteria: * Age 18 years or above * Born biological male * Self-identifies as MSM or transgender woman * Thai citizen * Resident in Bangkok or surrounding suburb * Had sex with a male partner at least once in the previous 12 months * Consents to participate in the study Exclusion Criteria: * Unable to perform any study procedures, or unable to commit to attend all study visits. * Has a serious medical, psychological, or substance use problem that, in the opinion of the study staff, would prevent appropriate participation or adequate follow-up in the trial Criteria: Stage 2 Inclusion Criteria: * Must meet all of the criteria in stage 1, plus: * Completed HIV test with result determined to be positive or negative * Agrees to return for follow-up visits with testing per protocol every 6 months for 18 months * Consents to participate in the study Exclusion Criteria: * Indeterminate HIV test result

What they're measuring

amphetamine-type stimulants (ATS)

Timeframe: 5 years

Trial details

NCT IDNCT03198962

SponsorThai Red Cross AIDS Research Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11-15